Similar Papers

Paper Title
Journal
Date
Author
The management of patients with leukaemia: the role of cytogenetics in this molecular era.
Christine J Harrison
British Journal of Haematology | VOL. 108
Christine J HarrisonChristine J Harrison
01 Jan 1999
Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
Nicolaus Kröger ... Michael R Bishop
Biology of Blood and Marrow Transplantation | VOL. 17
Nicolaus Kröger, et. al.Nicolaus Kröger ... Michael R Bishop
01 Nov 2010
The expression of SMN1, MART3, GLE1 and FUS genes in spinal muscular atrophy.
Aziza Alrafiah ... Sufana Almashhadi
Folia Histochemica et Cytobiologica | VOL. 56
Aziza Alrafiah, et. al.Aziza Alrafiah ... Sufana Almashhadi
08 Jan 2019
Intranuclear Aggregation of Mutant FUS/TLS as a Molecular Pathomechanism of Amyotrophic Lateral Sclerosis
Takao Nomura ... Yoshiaki Furukawa
Journal of Biological Chemistry | VOL. 289
Takao Nomura, et. al.Takao Nomura ... Yoshiaki Furukawa
01 Jan 2014
View more papers

More From: Blood research

Paper Title
Journal
Date
Author
Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?
Ye Li ... Wenming Chen
Blood Research | VOL. 60
Ye Li, et. al.Ye Li ... Wenming Chen
06 Feb 2025
Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysis
Shuku Sato ... Yotaro Tamai
Blood Research | VOL. 60
Shuku Sato, et. al.Shuku Sato ... Yotaro Tamai
05 Feb 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
Sung-Hoon Jung ... Kihyun Kim
Blood Research | VOL. 60
Sung-Hoon Jung, et. al.Sung-Hoon Jung ... Kihyun Kim
04 Feb 2025
Reversibility of acrocyanosis and improvement of capillaroscopic pattern in a patient with polycythemia vera treated with ruxolitinib: a case report.
Angelo Nigro
Blood research | VOL. 60
Angelo NigroAngelo Nigro
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.